Published in Nat Clin Pract Neurol on August 01, 2007
Myelination and support of axonal integrity by glia. Nature (2010) 3.54
Signals to promote myelin formation and repair. Nat Rev Neurol (2010) 1.95
Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat Neurosci (2009) 1.93
Molecular mechanisms of inherited demyelinating neuropathies. Glia (2008) 1.68
Charcot-Marie-Tooth disease. Eur J Hum Genet (2009) 1.45
Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain (2008) 1.22
Gliopathic pain: when satellite glial cells go bad. Neuroscientist (2009) 1.12
Organization and maintenance of molecular domains in myelinated axons. J Neurosci Res (2013) 1.06
Erbin is required for myelination in regenerated axons after injury. J Neurosci (2012) 0.99
Schwann cells as a therapeutic target for peripheral neuropathies. CNS Neurol Disord Drug Targets (2010) 0.92
Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling. PLoS One (2010) 0.92
Concepts for regulation of axon integrity by enwrapping glia. Front Cell Neurosci (2013) 0.91
Analysis of peripheral nerve expression profiles identifies a novel myelin glycoprotein, MP11. J Neurosci (2008) 0.91
Myelination and regional domain differentiation of the axon. Results Probl Cell Differ (2009) 0.90
Gene network revealed involvements of Birc2, Birc3 and Tnfrsf1a in anti-apoptosis of injured peripheral nerves. PLoS One (2012) 0.89
Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C. Hum Mol Genet (2013) 0.86
Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain (2012) 0.86
Microprocessor Complex Subunit DiGeorge Syndrome Critical Region Gene 8 (Dgcr8) Is Required for Schwann Cell Myelination and Myelin Maintenance. J Biol Chem (2015) 0.85
MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy. Am J Pathol (2010) 0.83
Glial cells: old cells with new twists. Acta Histochem (2007) 0.81
Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. Am J Hum Genet (2014) 0.81
Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration. Curr Biol (2016) 0.79
Peptide mimetic of the S100A4 protein modulates peripheral nerve regeneration and attenuates the progression of neuropathy in myelin protein P0 null mice. Mol Med (2013) 0.78
Foot pad skin biopsy in mouse models of hereditary neuropathy. Glia (2010) 0.78
Experimental therapeutics in hereditary neuropathies: the past, the present, and the future. Neurotherapeutics (2008) 0.76
Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy. Neural Plast (2012) 0.76
The HMGB1 signaling pathway activates the inflammatory response in Schwann cells. Neural Regen Res (2015) 0.75
Axonal neuregulin-1 regulates myelin sheath thickness. Science (2004) 6.09
Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A (2008) 3.74
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature (2012) 3.09
Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol (2014) 2.36
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron (2008) 2.27
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke. Stroke (2013) 2.07
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J Clin Psychiatry (2014) 2.01
Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci (2010) 1.59
A role for Schwann cell-derived neuregulin-1 in remyelination. Nat Neurosci (2012) 1.47
Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2004) 1.44
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics (2009) 1.36
The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol (2006) 1.23
Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain (2005) 1.21
Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain. Biol Psychiatry (2010) 1.21
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol (2007) 1.18
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol Med (2012) 1.17
Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry (2010) 1.17
Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract Res Clin Anaesthesiol (2010) 1.16
Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol (2008) 1.14
The structure and usage of female and male mouse ultrasonic vocalizations reveal only minor differences. PLoS One (2012) 1.13
The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry (2010) 1.10
Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology (2004) 1.09
Aberrant function and structure of retinal ribbon synapses in the absence of complexin 3 and complexin 4. J Cell Sci (2009) 1.05
Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain (2004) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. Glia (2009) 1.02
Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscul Disord (2008) 1.01
In vitro gender differences in neuronal survival on hypoxia and in 17beta-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab (2005) 1.01
Lithium enhances remyelination of peripheral nerves. Proc Natl Acad Sci U S A (2012) 1.01
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. EMBO Mol Med (2011) 1.00
Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behav Brain Res (2012) 0.99
5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci (2012) 0.99
Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol (2007) 0.97
Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci (2003) 0.95
ETB receptor deficiency causes salt-sensitive hypertension. J Mol Med (Berl) (2002) 0.95
The SNARE protein SNAP-29 interacts with the GTPase Rab3A: Implications for membrane trafficking in myelinating glia. J Neurosci Res (2009) 0.94
Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatr Serv (2006) 0.93
The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiol Dis (2010) 0.93
Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anat Embryol (Berl) (2005) 0.93
A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med (2012) 0.92
Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol Alcohol (2006) 0.92
Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Curr Med Res Opin (2004) 0.92
Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. Am J Pathol (2013) 0.91
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis. Acad Radiol (2013) 0.91
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia (2013) 0.90
Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. J Psychiatr Res (2004) 0.90
Erythropoietin: not just about erythropoiesis. Lancet (2010) 0.90
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet J Rare Dis (2014) 0.89
Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behav Brain Res (2009) 0.89
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology (Berl) (2011) 0.89
Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res (2006) 0.89
Gadofluorine M-enhanced magnetic resonance nerve imaging: comparison between acute inflammatory and chronic degenerative demyelination in rats. Exp Neurol (2007) 0.89
Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res (2003) 0.87
Erythropoietin improves operant conditioning and stability of cognitive performance in mice. BMC Biol (2009) 0.86
Propagation of spreading depression inversely correlates with cortical myelin content. Ann Neurol (2009) 0.86
A pilot study on the oral conditions of severely alcohol addicted persons. J Contemp Dent Pract (2003) 0.86
Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Mol Med (2012) 0.85
Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. J Neurosci (2011) 0.85
The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotroph Lateral Scler (2008) 0.85
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease. Br Med Bull (2012) 0.85
Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des (2010) 0.85
Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biol (2011) 0.85
Experimental Charcot-Marie-Tooth type 1A: a cDNA microarrays analysis. Mol Cell Neurosci (2005) 0.84
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials (2010) 0.84
Circadian modulation of GABA-mediated cortical inhibition. Cereb Cortex (2011) 0.84
Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry (2011) 0.83
Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neurosci Lett (2006) 0.83
Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cell Signal (2007) 0.83
Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury. Glia (2013) 0.82
Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis. Ther Adv Neurol Disord (2008) 0.82
Mild expression differences of MECP2 influencing aggressive social behavior. EMBO Mol Med (2014) 0.82
Monogenic heritable autism gene neuroligin impacts Drosophila social behaviour. Behav Brain Res (2013) 0.82
Melatonin as a candidate compound for neuroprotection in amyotrophic lateral sclerosis (ALS): high tolerability of daily oral melatonin administration in ALS patients. J Pineal Res (2002) 0.81
Mast cells and endothelin-1: a life-saving biological liaison? Trends Immunol (2005) 0.81
A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2011) 0.81
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Mol Med (2012) 0.81
Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivo. Brain Res (2002) 0.81
Chronic psychosocial stress in the absence of social support induces pathological pre-pulse inhibition in mice. Behav Brain Res (2009) 0.80
Cell type specific signalling by hematopoietic growth factors in neural cells. Neurochem Res (2006) 0.80
Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men. Alcohol Alcohol (2003) 0.80
Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Mol Med (2008) 0.79
Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis. Mol Cancer Ther (2009) 0.79
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain (2011) 0.79
Myelin disorders: Causes and perspectives of Charcot-Marie-Tooth neuropathy. J Mol Neurosci (2006) 0.79
Genetic markers of a Munc13 protein family member, BAIAP3, are gender specifically associated with anxiety and benzodiazepine abuse in mice and humans. Mol Med (2013) 0.79
Outpatient Long-term Intensive Therapy for Alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism. Dialogues Clin Neurosci (2007) 0.79
Effect of endothelin-1 on astrocytic protein content. Glia (2003) 0.79
Supervised disulfiram in the treatment of alcohol use disorder: a commentary. Alcohol Clin Exp Res (2011) 0.78
Arginine challenge unravels persistent disturbances of urea cycle and gluconeogenesis in abstinent alcoholics. Alcohol Alcohol (2006) 0.78
Erythropoietin augments survival of glioma cells after radiation and temozolomide. Int J Radiat Oncol Biol Phys (2008) 0.78
A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report. Bipolar Disord (2014) 0.78
Pre-embedding immunogold labeling of TUNEL stain enables evaluation of DNA strand breaks and ultrastructural alterations in individual cells of neuronal tissue. Acta Neuropathol (2002) 0.78
Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics (2010) 0.78
Fast cerebellar reflex circuitry requires synaptic vesicle priming by munc13-3. Cerebellum (2015) 0.77
Effects of cerebrovascular challenges on plasma endothelin. Neurosci Res (2002) 0.77
Preserved vasopressin response to osmostimulation despite decreased basal vasopressin levels in long-term abstinent alcoholics. Alcohol Clin Exp Res (2004) 0.77
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. Exp Neurol (2004) 0.77